Nitin Ohri, MD, MS

Montefiore Einstein Comprehensive Cancer Center
Bronx, NY, United States

Disclosures:

• Employment: none
• Compensation: Genentech: Consultant, Compensation Payment-End Date: to present ;Regeneron: Consultant-End Date: to present ;AstraZeneca: Consultant, Research Grants, Research Funding, Research Salary Support, Grant Research Funding, Honoraria-End Date: Present
• Ownership: none
• Leadership: none

Presentation(s):

• 190 - The Selective Personalized RadioImmunotherapy for Locally Advanced NSCLC Trial (SPRINT): Patient-Reported Outcomes

  Monday, September 30, 2024
  11:05 AM – 11:15 AM ET